• The European high yield (EHY) market had a flat performance in April, with a marginal negative return of -0.03%. During the month, the income return of +0.37% ended up compensating almost fully for some price weakness (price return of -0.40%). In April, the EHY market started with broadly positive momentum during the first ten days of the month, before experiencing a sharp drop around the middle of the period and then retracing the weakness partially during the second half of the month to fini...
• The European high yield (EHY) market had a flat performance in April, with a marginal negative return of -0.03%. During the month, the income return of +0.37% ended up compensating almost fully for some price weakness (price return of -0.40%). In April, the EHY market started with broadly positive momentum during the first ten days of the month, before experiencing a sharp drop around the middle of the period and then retracing the weakness partially during the second half of the month to fini...
The daily chart worsened significantly last week, violating our bullish view we communicated in the previous updates in combination with the bullish target for US$13,265/MT. This suggests that prices have topped within the accelerating move since the breakout above US$4,275/MT mid-January.
UBS reports strong 1Q24 numbers, upcoming higher capital requirements a positive for the senior debt layer. Strong numbers from UniCredit, potential for a new AT1. CAFFIL in the market with a 15yr covered bond. Triple green in bail-in senior – zeroing in on green BYLAN vs vanilla C. Erste Group Bank and Banco Santander manage their AT1 layers. Bank bond performance
UBS reports strong 1Q24 numbers, upcoming higher capital requirements a positive for the senior debt layer. Strong numbers from UniCredit, potential for a new AT1. CAFFIL in the market with a 15yr covered bond. Triple green in bail-in senior – zeroing in on green BYLAN vs vanilla C. Erste Group Bank and Banco Santander manage their AT1 layers. Bank bond performance
Within the previous update, the end of March, we mentioned the bullish break above the upper end of the falling trend channel in the weekly chart around the US$85.00/bbl level in the second half of March. This trend change improved the longer-term picture, as the corrective phase of the past two years has ended. This indicates a more sideways market between US$71.50/bbl and US$98.00/bbl in the weekly chart. There remains a bullish undertone as the completed falling wedge pattern in the daily cha...
The month of April ended 335bp lower at 129.94, which is confirming this year's correction. This chart and timeframe is weak and needs to improve before we should see a bottom here. A rise and close above the April high at 133.10 is necessary to expect a bottom. On the other hand, the weekly chart is improving. Prices closed 80bp higher at 131.02 last week. This resulted in a higher low and high in relation to the week before, suggesting prices are bottoming here. Looking at the weekly chart, th...
Cross-market volatility is falling again. This looks largely down to Friday's benign US jobs release and a relatively quiet US data calendar this week. We see the dollar trading ranges but are looking for some independent moves in the Swedish krona and British pound at this week's rate meetings. And lower volatility will keep the carry trade in demand.
US and euro rates opened the week lower, continuing the dovish sentiment from the week before. Markets are pricing in 75bp of ECB rate cuts for 2024 – our baseline forecast – but two cuts are also still on the table, and thus market pricing should be lower. A growth recovery, as also reflected by Monday's PMIs, reduces the need for a steep path of cuts
ASM has been a very strong performer over the past four years, with high adoption of its ALD and Epitaxy technology. We believe this run is far from over and expect very strong order momentum over the course of 2024, ahead of the start of 2nm volume production in 2025. We reiterate our BUY and increase our target price to €750 per share (from €650). ASM is on the ING Benelux Favourites list.
Following Allfunds' first quarter results, we update our forecasts and valuation for Allfunds. A slower pace in the recovery of AuA leads us to reduce our revenue and earnings forecasts but the re-rating of the peer group leads us to maintain our 12-month target price of €7.30 and BUY recommendation.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.